Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Cited by (1,001)

Items 201–300 of 1,001

1. The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia
   Viviane Labrie, John Roder · 2009 · Neuroscience & Biobehavioral Reviews
2. Identification of Candidate Coding Region Single Nucleotide Polymorphisms in 165 Human Genes Using Assembled Expressed Sequence Tags
   Kavita S. Garg, Philip Green, Deborah A. Nickerson · 1999 · Genome Research
3. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: A replication study
   Rael D. Strous, Karen A. Nolan, Raya Lapidus, Libna Diaz, Takuya Saito, Herbert M. Lachman · 2003 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
4. Genetics of human prefrontal function
   Georg Winterer, David A Goldman · 2003 · Brain Research Reviews
5. Drinking Green Tea Modestly Reduces Breast Cancer Risk
   Martha J. Shrubsole, Wei Lu, Zhi Chen, Xiao Ou Shu, Ying Zheng, Qi Dai, Qiuyin Cai, Kai Gu, Zhi-Xian Ruan, Yu‐Tang Gao et al. · 2008 · Journal of Nutrition
6. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele
   Dimitrios Avramopoulos, Nicholas C. Stefanis, Ioanna Hantoumi, Nikolaos Smyrnis, Ioannis Evdokimidis, C. N. STEFANIS · 2002 · Molecular Psychiatry
7. Depression and the role of genes involved in dopamine metabolism and signalling
   Esther Marije Opmeer, Rudie Kortekaas, André Aleman · 2010 · Progress in Neurobiology
8. Association of COMT Val158Met Genotype With Executive Functioning Following Traumatic Brain Injury
   Robert H. Lipsky, Molly B. Sparling, Laurie M. Ryan, Ke Xu, Andres M. Salazar, David A Goldman, Deborah L. Warden · 2005 · Journal of Neuropsychiatry
9. Overview of the pharmacogenomics of cigarette smoking
   Man Ho, Rachel Fynvola Tyndale · 2007 · The Pharmacogenomics Journal
10. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Jackie A. Lavigne, Julie E. Goodman, Tekum Fonong, Shelly-Ann Odwin, P He, David W. Roberts, James D. Yager · 2001 · PubMed
11. Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer
    Patricia A. Thompson, Christine B. Ambrosone · 2000 · JNCI Monographs
12. Pharmacogenetics of antidepressants
    Crisafulli, Concetta, Fabbri, Chiara, Porcelli, Stefano, Drago, Antonio, Spina, Edoardo, De Ronchi, Diana, Serretti, Alessandro · 2011 · Frontiers in Pharmacology
13. The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes
    Niki Antypa, Antonio Drago, Alessandro Serretti · 2013 · Neuroscience & Biobehavioral Reviews
14. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome
    Sarah E. Prasad, Sarah Howley, Kieran C. Murphy · 2008 · Developmental Disabilities Research Reviews
15. Genetics of chronic pain states
    Dan Buskila · 2007 · Best Practice & Research Clinical Rheumatology
16. MAO-A and COMT polymorphisms and gene effects in narcolepsy
    Yves A Dauvilliers, Elisabeth Neidhart, Michel Lecendreux, Michel M. Billiard, Mehdi Tafti · 2001 · Molecular Psychiatry
17. The Functional Val158Met Polymorphism of COMT Predicts Interindividual Differences in Brain α Oscillations in Young Men
    Sereina Bodenmann, Thomas Rusterholz, Roland Dürr, Claudia Stoll, Valérie Bachmann, Eva M. Geißler, Karin Jaggi-Schwarz, Hans‐Peter Landolt · 2009 · Journal of Neuroscience
18. Empirical support for an involvement of the mesostriatal dopamine system in human fear extinction
    Karolina A. Raczka, M-L Mechias, Nina Gartmann, Andreas Reif, J. Deckert, Mathias Pessiglione, Raffaël Kalisch · 2011 · Translational Psychiatry
19. Estrogen Deficient Male Mice Develop Compulsive Behavior
    Rachel Hill, Kerry J. McInnes, Emily C.H. Gong, Margaret E. E. Jones, Evan R. Simpson, Wah Chin Boon · 2006 · Biological Psychiatry
20. Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide
    Mark J. Russ, Herbert M. Lachman, Todd B. Kashdan, Takuya Saito, Senada Bajmakovic-Kacila · 2000 · Psychiatry Research
21. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review
    Joseph P. Schacht · 2016 · The Pharmacogenomics Journal
22. Theranostic Biomarkers for Schizophrenia
    Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, S. Uzun, O. Kozumplik, N. Pivac · 2017 · International Journal of Molecular Sciences
23. Association Between Catechol-O-Methyltransferase and Phobic Anxiety
    Monica McGrath, Ichiro I. Kawachi, Alberto Ascherio, Graham A. Colditz, David J. Hunter, Immaculata De Vivo · 2004 · American Journal of Psychiatry
24. Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients
    Amos Frisch, Neri Laufer, Yardena Danziger, Elena Michaelovsky, Shani Leor, Cynthia A. Carel, Dan Joseph Stein, Silvana Fennig, Marc Mimouni, Alan S. Apter et al. · 2001 · Molecular Psychiatry
25. Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment
    Vadim P. Yuferov, Orna Levran, Dmitri Proudnikov, David A. Nielsen, Mary Jeanne Kreek · 2010 · Annals of the New York Academy of Sciences
26. Catechol-O-Methyltransferase Contributes to Genetic Susceptibility Shared Among Anxiety Spectrum Phenotypes
    John M. Hettema, Seon‐Sook An, József Bukszár, Edwin J. C. G. van den Oord, Michael Churton Neale, Kenneth S. Kendler, Xiangning Chen · 2008 · Biological Psychiatry
27. Identification of Sequence Variants and Analysis of the Role of the Catechol-O-Methyl-Transferase Gene in Schizophrenia Susceptibility
    Maria Karayiorgou, Joseph A. Gogos, Brandi L. Galke, Paula S Wolyniec, Gerald Nestadt, Stylianos E. Antonarakis, Haig H. Kazazian, David E. Housman, Ann E. Pulver · 1998 · Biological Psychiatry
28. Basic concepts in the study of diseases with complex genetics
    Margit Burmeister · 1999 · Biological Psychiatry
29. Pharmacogenomics of Opioids and Perioperative Pain Management
    Senthilkumar Sadhasivam, Vidya Chidambaran · 2012 · Pharmacogenomics
30. Genetic variation in dopamine moderates neural response during reward anticipation and delivery: Evidence from event‐related potentials
    Dan Foti, Greg Hajcak · 2012 · Psychophysiology
31. Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1–5, MAOA, MAOB, TH, VMAT1, and VMAT2
    Elizabeth M. Tunbridge, Marco Narajos, Charlotte H. Harrison, Charles Beresford, Andrea Cipriani, Paul J. Harrison · 2019 · Biological Psychiatry
32. Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?
    Elisa Mura, Stefano M. Govoni, Marco Racchi, Carossa, Guglielmina Nadia Ranzani, Massimo Allegri, André van Schaik · 2013 · Journal of Pain Research
33. Recent progress in psychiatric genetics--some hope but no hype
    Scott F. Stoltenberg · 2000 · Human Molecular Genetics
34. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia
    Stefanie Malan‐Müller, Sanja Kilian, Leigh L. van den Heuvel, Soraya Bardien, Laila Asmal, Louise Warnich, Robin Alexander Emsley, Sian M. J. Hemmings, Soraya Seedat · 2015 · Schizophrenia Research
35. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia
    Murphy, Brenda C., O'Reilly, Richard L., Singh, Shiva M. · 2005 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
36. Impaired Executive Control Is Associated with a Variation in the Promoter Region of the Tryptophan Hydroxylase 2 Gene
    Martin Reuter, Ulrich Ott, Dieter Vaitl, Jürgen Hennig · 2007 · Journal of Cognitive Neuroscience
37. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health
    Craig A. Olsson, Richard Anney, Mehrnoush Lotfi-Miri, Graham B Byrnes, Robert Williamson, George C. Patton · 2005 · Psychiatric Genetics
38. Catechol-O-Methyltransferase Polymorphism Is Associated With Increased Uterine Leiomyoma Risk in Different Ethnic Groups
    Ayman A. Al-Hendy, Salama A. Salama · 2006 · Journal of the Society for Gynecologic Investigation
39. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder
    Katharina Domschke, Patricia Ohrmann, Miriam Braun, Thomas Suslow, Jochen Bauer, Christa Hohoff, Anette Kersting, Almut Engelien, Volker Arolt, Walter Leonhard Heindel et al. · 2008 · Psychiatry Research Neuroimaging
40. Demographic, structural and genetic predictors of late cognitive decline after penetrating head injury
    Vanessa Raymont, Ashley Dawn Greathouse, Katherine M. Reding, Robert H. Lipsky, Andres Μ. Salazar, Jordan Henry Grafman · 2007 · Brain
41. Inferring candidate genes for Attention Deficit Hyperactivity Disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS)
    M. Reuter, P. Kirsch, J. Hennig · 2006 · Journal of neural transmission
42. Association of the Val158Met Catechol O-Methyltransferase Genetic Polymorphism with Panic Disorder
    Claudia Rothe, Diana Koszycki, Jacques Bradwejn, Nicole A. King, Vincenzo De Luca, Subi Tharmalingam, Fabio M. Macciardi, Jürgen Deckert, James L Kennedy · 2006 · Neuropsychopharmacology
43. Impact of aerobic exercise training on cognitive functions and affect associated to the COMT polymorphism in young adults
    Sanna Stroth, Ralf K. Reinhardt, Jan Thöne, Katrin Hille, Matthias Schneider, Sascha Härtel, Wolfgang M. Weidemann, Klaus Bös, Manfred Spitzer · 2010 · Neurobiology of Learning and Memory
44. Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
    László E. Kiss, Patrı́cio Soares-da-Silva · 2014 · Journal of Medicinal Chemistry
45. Proline Affects Brain Function in 22q11DS Children with the Low Activity COMT158 Allele
    Jacob A. S. Vorstman, Bruce I. Turetsky, Monique E.J. Morcus, Monique G.M. de Sain–van der Velden, Bert Dorland, Mirjam Sprong, Eric F. Rappaport, Frits A. Beemer, Beverly S. Emanuel, René S. Kahn et al. · 2008 · Neuropsychopharmacology
46. Catechol-O-methyl Transferase and Expression of Schizophrenia in 73 Adults with 22q11 Deletion Syndrome
    Anne S. Bassett, Oana Caluseriu, Rosanna Weksberg, Donald A. Young, Eva W.C. Chow · 2007 · Biological Psychiatry
47. Catechol O-Methyltransferase Genetic Polymorphism in Panic Disorder
    Jong‐Min Woo, Kyung‐Sik Yoon, Bum‐Hee Yu · 2002 · American Journal of Psychiatry
48. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes
    Victor Chavarria, João Vian, C. Lopes Pereira, João Data-Franco, Brisa Simões Fernandes, Michael Berk, Seetal Dodd · 2017 · Clinical Therapeutics
49. The role of obesity in the pathogenesis of hypertension
    Yolanda E. Bogaert, Stuart L. Linas · 2008 · Nature Reviews Nephrology
50. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer
    Dong‐Seok Yim, Sue K. Park, Keun-Young Yoo et al. · 2001 · Pharmacogenetics
51. Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies
    Oussama Kébir, Karim Tabbane, Sarojini M. Sengupta, Ridha Joober · 2009 · Journal of Psychiatry and Neuroscience
52. Evidence for a common biological basis of the absorption trait, hallucinogen effects, and positive symptoms: Epistasis between 5-HT2a and COMT polymorphisms
    Ulrich Ott, Martin Reuter, Juergen Hennig, Dieter Vaitl · 2005 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
53. The phenotypes of bipolar disorder: relevance for genetic investigations
    GLENDA M. MacQUEEN, Tomáš Hájek, Martin Alda · 2005 · Molecular Psychiatry
54. The influence of the dopaminergic system on cognitive functioning: A molecular genetic approach
    Martin Reuter, Kristina Peters, Katrin Schroeter, Wolfgang Koebke, Daniela Lenardon, Birte Bloch, Juergen Hennig · 2005 · Behavioural Brain Research
55. Increased Prevalence of EGFR -Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms
    Daphne W. Bell, Brian W. Brannigan, Keitaro Matsuo, Dianne M. Finkelstein, Raffaella Sordella, Jeff Settleman, Tetsuya Mitsudomi, Daniel A. Haber · 2008 · Clinical Cancer Research
56. Biological and social influences on cognitive control processes dependent on prefrontal cortex
    Adele D. Diamond · 2011 · Progress in brain research
57. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone
    Yoshio Yamanouchi, Nakao Iwata, Taroh Suzuki, Tsuyoshi Kitajima, Masashi Ikeda, Norio Ozaki · 2003 · The Pharmacogenomics Journal
58. Genetic, personality, and environmental predictors of drug use in adolescents
    Bradley T. Conner, Gerhard Hellemann, Terry L. Ritchie, Ernest Pascal Noble · 2009 · Journal of Substance Abuse Treatment
59. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans
    Seong-Gene Lee, Yeonho Joo, Byungsu Kim, Seockhoon Chung, Hie Lim Kim, Inchul Lee, Bo Youl Choi, Changyoon Kim, Kyuyoung Song · 2005 · Human Genetics
60. Association Between the Functional Polymorphism of Catechol‐<i>O</i>‐Methyltransferase Gene and Alcohol Consumption Among Social Drinkers
    Kauhanen, Jussi, Hallikainen, Tero, Tuomainen, Tomi‐Pekka, Koulu, Markku, Karvonen, Matti K., Salonen, Jukka T, Tiihonen, Jari · 2000 · Alcoholism Clinical and Experimental Research
61. The Impact of Genetic Research on our Understanding of Normal Cognitive Ageing: 1995 to 2009
    Payton, Antony · 2009 · Neuropsychology Review
62. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia
    Marta Bosia, Margherita Bechi, Elena Marino, Simona Anselmetti, Sara Poletti, Federica Cocchi, Enrico Smeraldi, Roberto Cavallaro · 2007 · Neuroscience Letters
63. Association Study of Catechol- O-Methyltransferase Gene and Dopamine D4 Receptor Gene Polymorphisms and Personality Traits in Healthy Young Chinese Females
    Shih‐Jen Tsai, Chen‐Jee Hong, Younger W.‐Y. Yu, Tai‐Jui Chen · 2004 · Neuropsychobiology
64. The biological basis of anger: Associations with the gene coding for DARPP-32 (PPP1R1B) and with amygdala volume
    Martin Reuter, Bernd Weber, Christian J. Fiebach, Christian Erich Elger, Christian Montag · 2009 · Behavioural Brain Research
65. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women
    Michele L. Coté, Wonsuk Yoo, Angela S. Wenzlaff · 2009 · Carcinogenesis
66. Testing for linkage of eye tracking dysfunction and schizophrenia to markers on chromosomes 6, 8, 9, 20, and 22 in families multiply affected with schizophrenia
    Volker Arolt, Rebekka Lencer, Sabine Purmann, Manfred Sch�rmann, Bertram M�ller-Myhsok, Katja Krecker, EBERHARD SCHWINGER · 1999 · American Journal of Medical Genetics
67. Prefrontal-Related Functional Connectivities within the Default Network Are Modulated by COMTval158metin Healthy Young Adults
    Bing Liu, Ming Song, Jun Li, Yong Liu, Kuncheng Li, Chunshui Yu, Tianzi Jiang · 2010 · Journal of Neuroscience
68. Disentangling the molecular genetic basis of personality: From monoamines to neuropeptides
    Christian Montag, Martin Reuter · 2014 · Neuroscience & Biobehavioral Reviews
69. Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density
    Christopher A. Haiman, Susan E. Hankinson, Immaculata De Vivo · 2003 · Breast Cancer Research and Treatment
70. Aggressive behaviour in patients with schizophrenia is associated with catechol- O -methyltransferase genotype
    Graeme Jones, Stanley Zammit, Nadine Norton, Marian L. Hamshere, Steven J.M. Jones, Charis Milham, R. D. Sanders, Geraldine M. McCarthy, Lisa Anne Jones, A.G. Cardno et al. · 2001 · The British Journal of Psychiatry
71. Pain modality- and sex-specific effects of COMT genetic functional variants
    Inna Belfer, Samantha K. Segall, William R. Lariviere, Shad B. Smith, Feng Dai, Gary Douglas Slade, Naim U. Rashid, Jeffrey S. Mogil, Claudia M. Campbell, Robert Randolph Edwards et al. · 2013 · Pain
72. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics
    Osamu Ohmori, Takahiro Shinkai, Hideki Kojima, Takeshi Terao, Takashi Suzuki, Takashi Mita, Kazuhiko Abe · 1998 · Neuroscience Letters
73. Gene–Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres
    Sergio Modafferi, Xiali Zhong, André Kleensang, Yohei Murata, Francesca Fagiani, David Pamies, Helena T. Högberg, Vittorio Calabrese, Herbert M. Lachman, Thomas Härtung et al. · 2021 · Environmental Health Perspectives
74. Dopaminergic Enhancement of Cognitive Function
    Mitul Ashok Mehta, Wim J. Riedel · 2006 · Current Pharmaceutical Design
75. Untitled work
    Young · 2000 · 10.1002/1096-8628(20001009)96:5
76. Editorial: Pragmatics and statistics in psychiatric genetics
    Douglas F. Levinson · 1997 · American Journal of Medical Genetics
77. Common single nucleotide variants underlying drug addiction: more than a decade of research
    Kora‐Mareen Bühler, Elena Giné, Víctor Echeverry‐Alzate, Javier Calleja‐Conde, Fernando Rodrı́guez de Fonseca, José Antonio López‐Moreno · 2015 · Addiction Biology
78. Genetics of obsessive-compulsive disorders: new findings and challenges.
    M. Grados, J. Walkup, Samuel Walford · 2003 · Brain & development (Tokyo. 1979)
79. Genetic Variability in the Dopamine System (Dopamine Receptor D4, Catechol-O-Methyltransferase) Modulates Neurophysiological Responses to Gains and Losses
    Josep Marco‐Pallarés, David Cucurell, Toni Cunillera B, Ulrike M. Krämer, Estela Càmara, Wido Nager, Peter Bauer, Rebecca Schüle, Ludger J. Schöls, Thomas Frank Münte et al. · 2009 · Biological Psychiatry
80. Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder
    Tanya E. Froehlich, Jeffery N. Epstein, Todd G. Nick, Maria S. Melguizo Castro, Mark A. Stein, William B. Brinkman, Amanda J. Graham, Joshua M. Langberg, Robert S. Kahn · 2011 · Journal of the American Academy of Child & Adolescent Psychiatry
81. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence
    Jerzy Samochowiec, Jolanta Kucharska–Mazur, Anna Grzywacz, Marcin Jabłoński, Hans Rommelspacher, Agnieszka Samochowiec, Mariusz Sznabowicz, J Horodnicki, Leszek Michał Sagan, Justyna Pełka-Wysiecka · 2006 · Neuroscience Letters
82. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: No evidence for association or epistasis
    Nadine Norton, George Kirov, Stanley Zammit, Gaynor Jones, Susan Jones, Richard Owen, Michael Krawczak, Nigel M. Williams, Michael C. O’Donovan, Michael John Owen · 2002 · American Journal of Medical Genetics
83. Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia
    Diana Pinto Prata, Andrea Mechelli, Cynthia H.Y. Fu, Marco Picchioni, Timothea Toulopoulou, Elvira Bramon, Muriel Walshe, Robin M. Murray, David Andrew Collier, Philip K. McGuire · 2009 · Proceedings of the National Academy of Sciences
84. Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics
    Tanya E. Froehlich, J. McGough, M. Stein · 2010 · CNS Drugs
85. Catechol‐o‐methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
    Elizabeth M. Tunbridge, Philip W. J. Burnet, Monsheel Sodhi, Paul J. Harrison · 2003 · Synapse
86. The development of personality across the lifespan
    M. Brent Donnellan, Richard W. Robins · 2012 · Cambridge University Press eBooks
87. Temperament and brain networks of attention
    Michael I. Posner, Mary Klevjord Rothbart · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
88. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism
    G. Estrada, Mar Fatjó‐Vilas, Ma José Muñoz, Gabriel Pulido, M. J. Miñano, Edson Luiz Toledo, Josep Maria Illa, M. Martín, María L. Miralles, Salvador Miret et al. · 2011 · Acta Psychiatrica Scandinavica
89. The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study
    Matthew J. Kempton, Morgan Haldane, Jigar Jogia, T. Christodoulou, John F. Powell, David Andrew Collier, Steven Williams, Sophia Frangou · 2008 · The International Journal of Neuropsychopharmacology
90. A genetic association study of dopamine metabolism‐related genes and chronic headache with drug abuse
    Sabina Cevoli, Mirella Mochi, Chiara Scapoli, Nadia Marzocchi, Giulia Pierangeli, Luigi Alberto Pini, Pietro Cortelli, Paola Montagna · 2006 · European Journal of Neurology
91. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder
    Tina B. Lonsdorf, Christian Rück, Jan Bergström, Gerhard Andersson, Arne Öhman, Nils Lindefors, Martin Schalling · 2010 · BMC Psychiatry
92. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.
    Y. Dauvilliers, M. Tafti, H. Landolt · 2015 · Sleep Medicine Reviews
93. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility
    Hiroshi Hirata, Yuji Hinoda, Naoko Okayama, Yutaka Suehiro, Ken Kawamoto, Nobuyuki Kikuno, Joseph T. Rabban, Lee May Chen, Rajvir Dahiya · 2008 · Cancer
94. How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions
    Meriem Manaï, Henriët van Middendorp, Dieuwke Swaantje Veldhuijzen, Tom W. J. Huizinga, Andrea W.M. Evers · 2019 · PAIN Reports
95. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD
    Mark A. Bellgrove, Katharina Domschke, Ziarih Hawi, Aiveen Kirley, Celine Mullins, Ian Hamilton Robertson, Michael Gill · 2005 · Experimental Brain Research
96. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
    Katja Mitrunen, Nadejda Jourenkova, Vesa V Kataja, Matti J. Eskelinen, Veli‐Matti Kosma, Simone Benhamou, Daehee Kang, Harri Vainio, Matti I.J. Uusitupa, Ari Hirvonen · 2001 · PubMed
97. Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep
    Bodenmann, S, Xu, S, Luhmann, UFO, Arand, M, Berger, W, Jung, HH, Landolt, HP · 2009 · Clinical Pharmacology &amp; Therapeutics
98. The COMT Val/Met Polymorphism Modulates Effects of tDCS on Response Inhibition
    Vanessa Nieratschker, Christoph Kiefer, Katrin Elisabeth Giel, Rejko Krüger, Christian Plewnia · 2014 · Brain stimulation
99. The functional COMT polymorphism, Val158Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds
    Sarah E. Harris, Alan F. Wright, Caroline Hayward, John M. Starr, Lawrence J. Whalley, Ian J. Deary · 2005 · Neuroscience Letters
100. The Effects of COMT (Val108/158Met) and DRD4 (SNP -521) Dopamine Genotypes on Brain Activations Related to Valence and Magnitude of Rewards
     Estela Càmara, Ulrike M. Krämer, Toni Cunillera B, Josep Marco‐Pallarés, David Cucurell, Wido Nager, Anna Mestres-Missé, Peter Bauer, Rebecca Schüle, Ludger J. Schöls et al. · 2009 · Cerebral Cortex